Insmed | INSM

Aktienkurs
107.25
Täglich Wechseln
-0.16 -0.15%
Monatlich
2.66%
Jährlich
3.17%
Q3 Prognose
105.98

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-10-22 FY2026Q3 AM -0.61 -1.75
2026-07-30 FY2026Q2 AM -0.75 -1.70
2026-05-07 FY2026Q1 AM -0.76 -0.99 -1.42
2026-02-19 FY2025Q4 AM -1.54 -1.28 -1.32
2025-10-30 FY2025Q3 AM -1.75 -1.34 -1.27



Preis Chg Tag Jahr Datum
BioMarin Pharmaceutical 59.01 0.14 0.24% 0% 2026-07-24
Cytokinetics 81.21 -0.71 -0.87% 118.42% 2026-07-24
DBV Technologies 13.63 -0.23 -1.66% 44.16% 2026-07-24
Gilead Sciences 129.23 -1.63 -1.25% 11.21% 2026-07-24
Heron Therapeutics 0.45 -0.01 -1.31% -76.28% 2026-07-24
Insmed 107.25 -0.16 -0.15% 3.17% 2026-07-24
Novartis 153.87 4.31 2.88% 34.68% 2026-07-21
Ultragenyx Pharmaceutical 26.90 -0.12 -0.44% -1.61% 2026-07-24
Regeneron Pharmaceuticals 656.01 4.10 0.63% 16.50% 2026-07-24
Sarepta Therapeutics 15.68 -0.20 -1.26% 21.74% 2026-07-24

Preis Tag Jahr Datum
USND 24976 -161.87 -0.64% 18.32% 2026-07-24
US2000 2932 -9.92 -0.34% 29.67% 2026-07-24